News J&J's Remicade faces further biosimilar competition in US FDA approves Samsung Bioepis biosimilar.
News EU regulators back two more orphan drugs, question of pricin... Two orphan medicines are heading towards the European market, after regulators recommended rare disease drugs from Biogen and BioMarin.
News Charities unite to oppose NICE rare disease rules MPs to discuss controversial plan in special debate.
News After healthcare defeat, markets fear Trump's tax plans will... Trump could use executive powers to undermine system.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
